IMAC Holdings, Inc. (NASDAQ:IMAC), a specialty outpatient medical services provider, announced significant changes in its leadership and accounting practices, according to a recent SEC filing. On June 26, 2024, the company expanded its Board of Directors from three to five members and appointed Dr. Peter Beitsch and Dr. Matthew Schwartz as new directors.
Dr. Beitsch brings extensive experience in private medical practice specializing in melanoma and breast cancer, with a history of involvement in national surgical societies. Dr. Schwartz, a Radiation Oncologist, has served in leadership roles at Comprehensive Cancer Centers of Nevada and co-founded Las Vegas Cyberknife, showcasing his expertise in oncology and biotechnology.
In the same filing, IMAC Holdings disclosed the engagement of Marcum, LLP as its new independent registered public accounting firm, replacing Salberg & Company, P.A. This change comes after the fiscal year ended December 31, 2023, during which there were no disagreements or reportable events with Salberg that would have influenced their audit report, despite an explanatory paragraph expressing substantial doubt about the company's ability to continue as a going concern.
IMAC Holdings provided Salberg with a copy of the Form 8-K filing and has included a letter from Salberg dated July 2, 2024, as part of its exhibits, confirming their agreement with the statements made.
These strategic appointments and changes in the accounting firm are part of IMAC Holdings' ongoing efforts to strengthen its governance and financial oversight. The information for this report is based on the company's recent SEC filing.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.